Focus: Cancer Center Featured Story 2

Filters close
Newswise: Exploring Cancer and Health Data on Asian American and Pacific Islanders
Released: 19-May-2022 10:05 AM EDT
Exploring Cancer and Health Data on Asian American and Pacific Islanders
Rutgers Cancer Institute of New Jersey

Cancer health disparities are often identified from population-based surveillance data routinely captured by statewide cancer registries. Antoinette Stroup, PhD, of Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute – Designated Comprehensive Cancer Center together with RWJBarnabas Health and Rutgers School of Public Health is the director of the New Jersey State Cancer Registry (NJSCR), explores cancer and health data on the Asian American and Pacific Islander population.

Newswise: Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Released: 19-May-2022 10:05 AM EDT
Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Rutgers Cancer Institute of New Jersey

Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.

Released: 18-May-2022 12:05 PM EDT
Study Shows Family Medicine Physicians Face Many Barriers to Providing Medical Abortions
UC Davis Health

A study by UC Davis and UC San Francisco identified multiple barriers that family physicians navigate to provide abortion services to their patients. The barriers include lack of physician training and federal, state and institutional restrictions on providing medication abortion.

Released: 18-May-2022 11:00 AM EDT
MD Anderson Research Highlights for May 18, 2022
University of Texas M. D. Anderson Cancer Center

Current discoveries include a novel target for mutant colorectal cancers, advances in breast cancer metastases to the brain and bone, a new understanding for secondary leukemias, biomarkers for myelofibrosis treatment response, a computational tool for combining single-cell datasets, unique immune features of pre-cancerous pancreatic cysts, encouraging clinical results for Ewing sarcoma and a new protein critical for T cells to mount an anti-tumor immune response.

Released: 18-May-2022 8:05 AM EDT
Moffitt Researchers Identify Tumor-Based Methylation Patterns as Cancer Biomarkers
Moffitt Cancer Center

In a new study featured on the cover of the May 1 issue of the journal Cancer Research, Moffitt Cancer Center researchers report on their identification of biomarkers based on a type of genetic modification called methylation that predicts the type of tumor immune environment and patient outcomes.

Newswise: UC Davis Health performs first robotic-assisted bronchoscopy procedure
Released: 17-May-2022 11:50 AM EDT
UC Davis Health performs first robotic-assisted bronchoscopy procedure
UC Davis Health

UC Davis Health physicians have performed the first single anesthesia diagnosis to treatment of lung cancer utilizing a fully robotic approach in the UC Health System. Procedure allows physicians to diagnose and remove lung cancer mass during single surgery.

Newswise: Jennifer Willcox named Senior Vice President, General Counsel and Chief Governance Officer at Dana-Farber Cancer Institute
Released: 16-May-2022 10:00 AM EDT
Jennifer Willcox named Senior Vice President, General Counsel and Chief Governance Officer at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute names new Senior Vice President, General Counsel and Chief Governance Officer

Newswise: Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer
Released: 13-May-2022 10:10 AM EDT
Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer
University of Texas M. D. Anderson Cancer Center

Adolescent and young adult survivors of acute lymphoblastic leukemia and acute myeloid leukemia, two of the most common leukemias for ages 15 to 39 years old, have increased risk of mortality than the general population for decades after initial diagnosis. Researchers investigated disparities specific to survivorship to learn about patients’ outcomes after they survived their initial diagnosis; and analyzed data from cancer survivors who were at least five years post treatment. Results suggest there is a gap in critical data surveillance that needs to be examined to further understand what is impacting long-term survivorship for AYAs.

Newswise: New Research in JNCCN Encourages Harnessing Health Technology to Help Cancer Patients Quit Smoking
10-May-2022 4:05 PM EDT
New Research in JNCCN Encourages Harnessing Health Technology to Help Cancer Patients Quit Smoking
National Comprehensive Cancer Network® (NCCN®)

A new study in JNCCN finds patients with cancer who smoke are more likely to receive evidence-based cessation assistance by using the ELEVATE program, increasing the likelihood of better outcomes.

Newswise: Discovery of Cell Protein That Keeps Kaposi’s Sarcoma Herpesvirus Dormant
Released: 11-May-2022 12:30 PM EDT
Discovery of Cell Protein That Keeps Kaposi’s Sarcoma Herpesvirus Dormant
UC Davis Comprehensive Cancer Center

A study led by UC Davis Cancer Center identified a binding protein in cancer cell’s nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body’s immune system. CHD4 is linked to cancer cell growth in many types of cancers.

Newswise: COVID-19 Vaccine Effective in People Receiving Cancer Treatment, Study Finds
Released: 11-May-2022 12:15 PM EDT
COVID-19 Vaccine Effective in People Receiving Cancer Treatment, Study Finds
University of Kansas Cancer Center

About 95% of participants achieved a measurable immune response after vaccination, according to study published in JAMA Oncology.

Newswise: Ludwig MSK Study Modeling Tumor Evolution Reveals a Vulnerability for Cancer Prevention and Therapy
Released: 11-May-2022 11:05 AM EDT
Ludwig MSK Study Modeling Tumor Evolution Reveals a Vulnerability for Cancer Prevention and Therapy
Ludwig Cancer Research

Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of genes essential to cancer growth appear to be more frequently mutated than others in established tumors.

Newswise: Celebrating Exceptional Service in Nursing at Memorial Sloan Kettering Cancer Center: Third Annual Robbins Family Awards
Released: 11-May-2022 9:20 AM EDT
Celebrating Exceptional Service in Nursing at Memorial Sloan Kettering Cancer Center: Third Annual Robbins Family Awards
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service.

Newswise: Honoring Rutgers Cancer Institute of New Jersey Nurses
Released: 11-May-2022 8:05 AM EDT
Honoring Rutgers Cancer Institute of New Jersey Nurses
Rutgers Cancer Institute of New Jersey

Two nurses are named recipients of Rutgers Cancer Institute’s ‘Oncology Nursing Excellence Awards’ during Nurses Week each year. This year’s award recipients were named during the annual Elizabeth Gibby Osborne Lecture today.

Released: 11-May-2022 8:00 AM EDT
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA)

A phase 2 clinical trial testing novel immunotherapy combinations in aggressive ovarian cancer has opened and first patients have begun treatment.

Released: 10-May-2022 11:20 AM EDT
Moffitt Researchers Identify Pathway that Regulates Lipid Synthesis and Contributes to Tumor Survival
Moffitt Cancer Center

In a new study published in the journal Cell Reports, Moffitt Cancer Center researchers show that cancer cells in an acidic environment undergo lipid synthesis and accumulation. The team identified the key signaling molecules responsible for these changes and discovered that these alterations are associated with poor outcomes and disease progression among breast cancer patients.

Newswise: Treatment Efficacy Score a Better Way to Predict Long-Term Survival in Breast Cancer Trials
Released: 10-May-2022 10:05 AM EDT
Treatment Efficacy Score a Better Way to Predict Long-Term Survival in Breast Cancer Trials
Yale Cancer Center

In a study led by Dr. Lajos Pusztai, Professor of Medicine (Medical Oncology) at Yale Cancer Center, researchers across various institutions, and on behalf of the I-SPY consortium, developed a novel continuous residual cancer based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in preoperative breast cancer trials.

Newswise: How do Patients Feel about Using AI in Healthcare?
Released: 10-May-2022 9:35 AM EDT
How do Patients Feel about Using AI in Healthcare?
Yale Cancer Center

New research from Yale Cancer Center provides a new understanding of patients’ views of artificial intelligence (AI) in health care. W

Newswise: Moffitt Researchers Identify Key Factors Impacting Adaptive Therapy
Released: 9-May-2022 11:25 AM EDT
Moffitt Researchers Identify Key Factors Impacting Adaptive Therapy
Moffitt Cancer Center

Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center have been investigating an alternative treatment approach called adaptive therapy that focuses on maintaining disease control instead of complete tumor cell elimination. In a new study published in Communications Medicine, the researchers used mathematical modeling to reveal that the spatial organization of a tumor is an important factor that governs how cells compete with one another and the effectiveness of adaptive therapy.

8-May-2022 11:00 AM EDT
Targeting Interleukin-6 Could Help Relieve Immunotherapy Side Effects
University of Texas M. D. Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6).

Released: 4-May-2022 12:05 PM EDT
MD Anderson Research Highlights for May 4, 2022
University of Texas M. D. Anderson Cancer Center

Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection.

Released: 4-May-2022 10:05 AM EDT
Moffitt Researchers Discover New Target for CAR T Cells in Solid Tumors
Moffitt Cancer Center

In a new study published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research, Moffitt Cancer Center researchers share the identification of a new potential target for CAR T cells called OR2H1 that they have demonstrated inhibits growth in lung and ovarian tumors

Newswise: AACI Welcomes New Member, Koch Institute for Integrative Cancer Research at MIT
Released: 2-May-2022 3:00 PM EDT
AACI Welcomes New Member, Koch Institute for Integrative Cancer Research at MIT
Association of American Cancer Institutes (AACI)

The Association of American Cancer Institutes (AACI) welcomes its newest member, the Koch Institute for Integrative Cancer Research at MIT.

Newswise: Extensive Research Underway to Address Cancer Disparities
Released: 2-May-2022 12:00 PM EDT
Extensive Research Underway to Address Cancer Disparities
Rutgers Cancer Institute of New Jersey

To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research (AACR), is recognized during May. Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, has curated a selection of ongoing research focusing on cancer disparities which features members from the Cancer Health Equity Center of Excellence.

Newswise: 5 Tips to Boost Bladder Health
Released: 2-May-2022 12:00 PM EDT
5 Tips to Boost Bladder Health
Rutgers Cancer Institute of New Jersey

Saum Ghodoussipour, MD, urologic oncologist and director of the Bladder and Urothelial Cancer Program at Rutgers Cancer Institute and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more on bladder health.

Newswise: Noninvasive Brain Tumor Treatment Allows Physicians to treat tumors with Pinpoint Accuracy
Released: 2-May-2022 12:00 PM EDT
Noninvasive Brain Tumor Treatment Allows Physicians to treat tumors with Pinpoint Accuracy
Rutgers Cancer Institute of New Jersey

Joseph P. Weiner, MD, radiation oncologist at Rutgers Cancer Institute and assistant professor of radiation oncology at Rutgers Robert Wood Johnson Medical School, who specializes in malignant and benign cancers of the brain and spine shares more about Gamma knife, a non-surgical treatment option that uses high doses of precisely focused radiation beams to destroy cancer cells and non-cancerous tumors.

Newswise: Exploring Sun Protection Behaviors among U.S. Hispanic Outdoor Workers
Released: 2-May-2022 8:00 AM EDT
Exploring Sun Protection Behaviors among U.S. Hispanic Outdoor Workers
Rutgers Cancer Institute of New Jersey

Carolyn J. Heckman, PhD, co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is corresponding author and shares more on unburns and sun protection behaviors among male Hispanic outdoor day laborers in the Northeast U.S.

Newswise: How Common is Skin Cancer? And More Questions You’re Afraid to Ask
Released: 2-May-2022 8:00 AM EDT
How Common is Skin Cancer? And More Questions You’re Afraid to Ask
Rutgers Cancer Institute of New Jersey

Sarah Weiss, MD, medical oncologist at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, answers questions about skin cancer and sun protection that you may be wondering

Newswise: Roswell Park Nursing Teams Present Findings at 2022 Oncology Nursing Society Annual Meeting
Released: 29-Apr-2022 5:05 PM EDT
Roswell Park Nursing Teams Present Findings at 2022 Oncology Nursing Society Annual Meeting
Roswell Park Comprehensive Cancer Center

Several nursing teams from Roswell Park Comprehensive Cancer Center were invited to share their research at the 47th Annual Congress of the Oncology Nursing Society (ONS), which is underway in Anaheim, California, and continues through May 1, 2022.

Released: 28-Apr-2022 10:00 AM EDT
MD Anderson and Community Health Network Announce Partnership to Create Fully Integrated Cancer Program
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Indianapolis-based Community Health Network today announced a partnership agreement to create Community Health Network MD Anderson Cancer Center. A comprehensive clinical and research cancer program collaboration in central Indiana, Community MD Anderson will provide Hoosier cancer patients greater access to some of the most advanced oncology care.

Released: 27-Apr-2022 9:40 AM EDT
Moffitt Researchers Develop Model to Predict Patients with Poor Lung Cancer Outcomes
Moffitt Cancer Center

Moffitt Cancer Center researchers are working to improve the ability to identify patients who are at a higher risk of poor survival through radiomics, an area of science that uses imaging, such as CT scans and MRIs, to uncover tumoral patterns and characteristics that may not be easy to spot by the naked eye. Results of their newest study was published today in Cancer Biomarkers.

Released: 27-Apr-2022 8:35 AM EDT
Updated Guidance for COVID-19 Vaccination from NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis provides expert consensus to help guide cancer care providers on latest research, available at NCCN.org/covid-19.

Released: 26-Apr-2022 2:05 PM EDT
Blasting Bladder Cancer
University of New Mexico Comprehensive Cancer Center

Bladder cancer affects nearly 84,000 people in the United States each year, making it the sixth most common cancer. Most people survive it, but unfortunately, many lose their bladders. Neda Hashemi, MD, and her team at The University of New Mexico Comprehensive Cancer Center are now offering several clinical trials, including one that will give people with bladder cancer a chance to fight their disease and keep their bladders.

Newswise: Rutgers Cancer Institute of New Jersey Nurses to Share Knowledge and Best Practices during 47th Annual Oncology Nursing Society Congress
Released: 26-Apr-2022 1:05 PM EDT
Rutgers Cancer Institute of New Jersey Nurses to Share Knowledge and Best Practices during 47th Annual Oncology Nursing Society Congress
Rutgers Cancer Institute of New Jersey

Oncology Nurses from Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health will be presenting at the Oncology Nursing Society’s (ONS) 47th Annual Congress being held April 27 to May 1 in Anaheim, California.

Newswise: Cancer center launches Center for Advancing Cancer Health Equity
Released: 25-Apr-2022 10:05 AM EDT
Cancer center launches Center for Advancing Cancer Health Equity
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center has launched the Center for Advancing Cancer Health Equity. The new center will work to improve health outcomes in underserved populations and help shape cancer-related policy decisions at the county, state, and national levels.

Newswise: Combination Immunotherapy Improves Outcomes for Patients with Non-small Cell Lung Cancer
Released: 25-Apr-2022 9:45 AM EDT
Combination Immunotherapy Improves Outcomes for Patients with Non-small Cell Lung Cancer
Yale Cancer Center

The phase 2 clinical trial of a multi-center study known as the COAST clinical trial has demonstrated improved outcomes using immunotherapy combinations for patients with unresectable stage III non-small cell lung cancer, according to researchers at Yale Cancer Center and participating organizations.

Newswise: NCCN Foundation Announces Awards for Rising Cancer Research Leaders
Released: 25-Apr-2022 8:55 AM EDT
NCCN Foundation Announces Awards for Rising Cancer Research Leaders
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network’s Oncology Research Program to oversee projects from early-career investigators advancing key areas for study in cancer care and biology, such as novel combination therapy, equitable access to cellular therapies, immune cell dysfunction, liquid biomarkers, genetic ancestry, oncogenic vulnerabilities, and MAIT cell antitumor activity.

Newswise: American Cancer Society Grants Help Cancer Patients Overcome Transportation Barriers
Released: 25-Apr-2022 7:30 AM EDT
American Cancer Society Grants Help Cancer Patients Overcome Transportation Barriers
Rutgers Cancer Institute of New Jersey

The American Cancer Society has awarded Rutgers Cancer Institute $60,000 in patient transportation and lodging grants, which will help alleviate the financial burden of transportation and lodging costs for cancer patients.

Newswise: jens_hillengass_myeloma_header.jpg
Released: 23-Apr-2022 10:05 AM EDT
Roswell Park Specialists to Highlight Latest Advances in Blood Cancer Treatment and Cellular Therapy
Roswell Park Comprehensive Cancer Center

oswell Park Comprehensive Cancer Center specialists will share the latest advances and developments in the treatment of blood-related cancers at the 2022 Tandem Transplantation & Cellular Therapy Meetings of American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, Utah, from April 23 to 26.

Newswise: Roswell Park CIO Leading University at Buffalo Advanced Cyberinfrastructure Research Effort; Team Earns $10M Grant
Released: 22-Apr-2022 1:00 PM EDT
Roswell Park CIO Leading University at Buffalo Advanced Cyberinfrastructure Research Effort; Team Earns $10M Grant
Roswell Park Comprehensive Cancer Center

The University at Buffalo will lead a $10 million project to develop software that academia, industry and government agencies use to manage high-performance computing infrastructure, the U.S. National Science Foundation (NSF) announced on Friday.

Released: 21-Apr-2022 12:30 PM EDT
New initiative to make UC Davis Health a leader in organ transplant equity
UC Davis Health

A new initiative called Pluralist will challenge the current paradigm and pursue equity in organ transplantation. The effort will place particular emphasis on communities of color in Sacramento and throughout California by using education intervention tools like social networks and digital media.

Released: 21-Apr-2022 11:10 AM EDT
New Chief of Bone Marrow Transplant and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Ira Braunschweig, MD, as chief, Section of Transplant and Cell Therapy at Rutgers Cancer Institute, chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line, and director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital, an RWJBarnabas facility.

Released: 19-Apr-2022 11:05 AM EDT
Cancer burden facing Asian Americans partly caused by racism
UC Davis Comprehensive Cancer Center

Racism facing Asian Americans is compounding existing cancer inequities. They are the first U.S. population group to experience cancer as the leading cause of death. A commentary in the Journal of the American Cancer Institute outlines the factors contributing to this.

Newswise: Memorial Sloan Kettering Cancer Center Announces The Starr Foundation Program for Discovery Science
Released: 19-Apr-2022 9:00 AM EDT
Memorial Sloan Kettering Cancer Center Announces The Starr Foundation Program for Discovery Science
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation.

Newswise: MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers
Released: 19-Apr-2022 9:00 AM EDT
MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers
University of Texas M. D. Anderson Cancer Center

MD Anderson awarded more than $10 million in grants to support collaborative research teams working to advance novel interception and treatment strategies that will improve outcomes for several cancer types with the greatest unmet need, including pancreatic cancer, ovarian cancer and glioblastoma (GBM).

Released: 18-Apr-2022 6:05 AM EDT
Filling in the Gaps
University of New Mexico Comprehensive Cancer Center

With all that the Land of Enchantment has to offer, skin cancer isn’t on the top on anyone’s list. But abundant sunshine and a dearth of dermatologists in the state pose a challenge for detecting and treating the various forms of skin cancer. Skin Cancer Screening clinics are now resuming. The first of several new clinics will be held in Albuquerque on Saturday, May 7. More are planned over the coming year in Gallup, Taos and southern New Mexico.

Released: 18-Apr-2022 6:05 AM EDT
Filling in the Gaps
University of New Mexico Comprehensive Cancer Center

With all that the Land of Enchantment has to offer, skin cancer isn’t on the top on anyone’s list. But abundant sunshine and a dearth of dermatologists in the state pose a challenge for detecting and treating the various forms of skin cancer. Skin Cancer Screening clinics are now resuming. The first of several new clinics will be held in Albuquerque on Saturday, May 7. More are planned over the coming year in Gallup, Taos and southern New Mexico.

Newswise: Yale findings broaden the repertoire of cancer-relevant genes
Released: 14-Apr-2022 12:05 PM EDT
Yale findings broaden the repertoire of cancer-relevant genes
Yale Cancer Center

Following an analysis of over 12,000 human genes, research from Yale Cancer Center indicates there is cancer-relevant importance in a much larger proportion of human genes than current cancer research models suggest.


Showing results

150 of 2888

close
1.03021